156 related articles for article (PubMed ID: 24067139)
1. Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma.
Valencia-Hipόlito A; Hernández-Atenógenes M; Vega GG; Maldonado-Valenzuela A; Ramon G; Mayani H; Peña Alonso Y; Martinez-Maza O; Méndez-Tenorio A; Huerta-Yepez S; Bonavida B; Vega MI
Leuk Lymphoma; 2014 Aug; 55(8):1806-14. PubMed ID: 24067139
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
[TBL] [Abstract][Full Text] [Related]
3. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of chemotherapy in Chinese patients with AIDS-related Burkitt lymphoma and diffuse large B-cell lymphoma: An observational study.
Xiao J; Du S; Dai G; Gao G; Yang D; Zhao H
Sci Rep; 2017 May; 7(1):1905. PubMed ID: 28507339
[TBL] [Abstract][Full Text] [Related]
5. New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma.
Frick M; Dörken B; Lenz G
Best Pract Res Clin Haematol; 2012 Mar; 25(1):3-12. PubMed ID: 22409819
[TBL] [Abstract][Full Text] [Related]
6. Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma.
Nomura Y; Yoshida S; Karube K; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
Cancer Sci; 2008 Aug; 99(8):1564-9. PubMed ID: 18754867
[TBL] [Abstract][Full Text] [Related]
7. Pediatric B-cell lymphoma, unclassifiable, with intermediate features between those of diffuse large B-cell lymphoma and Burkitt lymphoma: a report of two cases.
Zhang S; Wilson D; Czader M
Ann Lab Med; 2015 Mar; 35(2):254-6. PubMed ID: 25729731
[No Abstract] [Full Text] [Related]
8. A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas.
Kujawski LA; Longo WL; Williams EC; Turman NJ; Brandt N; Mosher DF; Eickhoff JC; Kahl BS
Cancer Invest; 2007 Mar; 25(2):87-93. PubMed ID: 17453819
[TBL] [Abstract][Full Text] [Related]
9. Clinical profile, outcome and challenges in the management of pediatric Burkitt lymphoma: a single center experience.
Chauhan P; Gupta A; Mandelia A; Yadav S; Rahman K; Nityanand S
Pediatr Hematol Oncol; 2021 May; 38(4):305-318. PubMed ID: 33646922
[TBL] [Abstract][Full Text] [Related]
10. Prognostic effect of Ki-67 expression in rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-treated diffuse large B-cell lymphoma is limited to non-germinal center B-cell-like subtype in late-elderly patients.
Koh YW; Hwang HS; Park CS; Yoon DH; Suh C; Huh J
Leuk Lymphoma; 2015; 56(9):2630-6. PubMed ID: 25573205
[TBL] [Abstract][Full Text] [Related]
11. [Primary gastric lesion in Berkitt-like lymphoma].
Zvonkov EE; Boriakh EA; Magomedova AU; Kravchenko SK; Kremenetskaia AM; Obukhova TN; Kaplanskaia IB; Samoĭlova RS; Makhinia VA; Shavlokhov VS; Krasil'nikova BB; Egorova EK; Danishian KI
Ter Arkh; 2005; 77(7):85-8. PubMed ID: 16116918
[No Abstract] [Full Text] [Related]
12. [Clinicopathological and molecular genetic characteristics of childhood diffuse large B cell lymphoma].
Huang H; Yang WP; Xu HY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):209-11. PubMed ID: 22780976
[No Abstract] [Full Text] [Related]
13. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
Bowman WP; Shuster JJ; Cook B; Griffin T; Behm F; Pullen J; Link M; Head D; Carroll A; Berard C; Murphy S
J Clin Oncol; 1996 Apr; 14(4):1252-61. PubMed ID: 8648381
[TBL] [Abstract][Full Text] [Related]
14. Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil.
Sandlund JT; Fonseca T; Leimig T; Verissimo L; Ribeiro R; Lira V; Berard CW; Sixbey J; Crist WM; Mao L; Chen G; Pui CH; Heim M; Pedrosa F
Leukemia; 1997 May; 11(5):743-6. PubMed ID: 9180301
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H
Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129
[TBL] [Abstract][Full Text] [Related]
16. How I treat Burkitt lymphoma in adults.
Jacobson C; LaCasce A
Blood; 2014 Nov; 124(19):2913-20. PubMed ID: 25258344
[TBL] [Abstract][Full Text] [Related]
17. Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.
Pillon M; Mussolin L; Carraro E; Conter V; Aricò M; Vinti L; Garaventa A; Piglione M; Buffardi S; Sala A; Santoro N; Lo Nigro L; Mura R; Tondo A; Casale F; Farruggia P; Pierani P; Cesaro S; d'Amore ES; Basso G
Br J Haematol; 2016 Nov; 175(3):467-475. PubMed ID: 27392319
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with modified CHOP-rituximab in pediatric AIDS-related advanced stage Burkitt lymphoma.
Crosswell HE; Bergsagel DJ; Yost R; Lew G
Pediatr Blood Cancer; 2008 Apr; 50(4):883-5. PubMed ID: 17278123
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center.
Tanyildiz HG; Dincaslan H; Yavuz G; Unal E; Ikinciogulları A; Dogu F; Tacyildiz N
J Clin Immunol; 2016 Oct; 36(7):667-76. PubMed ID: 27492260
[TBL] [Abstract][Full Text] [Related]
20. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
